Table 3.
Data from HNSCC patients' serum employed to isolate circulating immune complexes.
| Sample | Localization | Stage | Sex | Age | Differentiation | MUC1 In CIC | MUC1 in IHQ | MUC1-CT in IHQ | CIC levels (OD) | MUC1 serum levels (U/mL) |
| 1 | Larynx | I | M | 52 | Poorly | + | - | - | 0.306 | 3.9 |
| 2 | Larynx | III | M | 64 | Well | + | - | - | 0.371 | 1.4 |
| 3 | Larynx | III | M | 56 | Moderately | + | - | + | 0.320 | 1.2 |
| 4 | Larynx | III | M | 70 | Moderately | + | - | + | 0.229 | 0.9 |
| 5 | Larynx | IVA | M | 58 | Poorly | - | - | + | 0.411 | 2.2 |
| 6 | Larynx | IVA | M | 53 | Moderately | - | - | + | 0.312 | 1.7 |
| 7 | Oral Cavity | IVA | M | 55 | Moderately | - | + | + | 0.322 | 4.7 |
| 8 | Oral Cavity | IVA | F | 29 | Moderately | + | - | + | 0.258 | 1.7 |
| 9 | Oral Cavity | IVA | M | 68 | Moderately | + | - | + | 0.323 | 1.1 |
| 10 | Oral Cavity | IVA | M | 55 | Moderately | - | - | - | 0.477 | 0.6 |
| 11 | Oral Cavity | IVA | M | 49 | Well | - | - | + | 0.403 | 0.7 |
| 12 | Pharynx | IVA | M | 56 | Moderately | - | - | - | 0.497 | 5.3 |
| 13 | Pharynx | IVA | M | 65 | Moderately | + | - | + | 0.335 | 1.9 |
| 14 | Pharynx | IVA | M | 38 | Poorly | + | + | + | 0.231 | 1.8 |
| 15 | Pharynx | IVA | M | 72 | Moderately | - | - | - | 0.473 | 0.4 |
| 16 | Pharynx | IVB | M | 61 | Moderately | - | - | + | 0.349 | 1.5 |
| Positive/Total or mean value | 8/16 | 2/16 | 11/16 | 0.351 | 2.0 | |||||
Clinical data with immunohistochemical detection and serum determination of MUC1, anti-MUC1 Abs and circulating immune complexes are depicted.